181 related articles for article (PubMed ID: 34616126)
1. Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate.
Bae KN; Shin K; Kim HS; Kim BS; Kim MB; Ko HC
Ann Dermatol; 2021 Oct; 33(5):448-455. PubMed ID: 34616126
[TBL] [Abstract][Full Text] [Related]
2. Infantile hemangiomas with minimal or arrested growth: a retrospective case series.
Suh KY; Frieden IJ
Arch Dermatol; 2010 Sep; 146(9):971-6. PubMed ID: 20855695
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
[TBL] [Abstract][Full Text] [Related]
4. Infantile Hemangiomas with Minimal or Arrested Growth - Do They Occur More Often in Premature Infants Than It Seemed?
Matić A; Matić M; Prćić S; Gajić M
Acta Dermatovenerol Croat; 2021 Nov; 29(4):196-202. PubMed ID: 36896690
[TBL] [Abstract][Full Text] [Related]
5. Good Clinical Responders to Topical Timolol in Patients with Infantile Hemangiomas: A 7-Year Retrospective Study of 328 Korean Patients.
Yu DA; Min SH; Song J; Park JS; Lee H; Ohn J; Kim KH
Ann Dermatol; 2022 Oct; 34(5):360-369. PubMed ID: 36198627
[TBL] [Abstract][Full Text] [Related]
6. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas.
Anwar F; Mahmood E; Sharif S; Shah R; Jamgochian M; Ouellette S; Umar M; Rao B
J Drugs Dermatol; 2023 Jun; 22(6):594-598. PubMed ID: 37276157
[TBL] [Abstract][Full Text] [Related]
7. Infantile hemangiomas with minimal or arrested growth associated with soft tissue hypertrophy: a case series of 10 patients.
Planas-Ciudad S; Roé Crespo E; Sánchez-Carpintero I; Frieden IJ; Martín-Santiago A; Redondo Bellón P; Moreno Artero E; Osier E; Puig Sanz L; Baselga Torres E
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1924-1929. PubMed ID: 28681397
[TBL] [Abstract][Full Text] [Related]
8. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma.
Wu HW; Liu C; Wang X; Zhang L; Yuan W; Zheng JW; Su LX; Fan XD
Front Oncol; 2017; 7():137. PubMed ID: 28702374
[TBL] [Abstract][Full Text] [Related]
9. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
Danarti R; Ariwibowo L; Radiono S; Budiyanto A
Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
[TBL] [Abstract][Full Text] [Related]
10. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.
Chakkittakandiyil A; Phillips R; Frieden IJ; Siegfried E; Lara-Corrales I; Lam J; Bergmann J; Bekhor P; Poorsattar S; Pope E
Pediatr Dermatol; 2012; 29(1):28-31. PubMed ID: 22150436
[TBL] [Abstract][Full Text] [Related]
11. Topical Timolol Combined Intralesional Injection of Diprospan in the Treatment of Elevated Localized Mixed Infantile Hemangiomas and a Discussion for Proper Timing for Injection.
Zhang JY; Lan SJ; Liu M; Yang TY; Liu SS; Rong L
J Craniofac Surg; 2021 May; 32(3):988-990. PubMed ID: 33538448
[TBL] [Abstract][Full Text] [Related]
12. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
[TBL] [Abstract][Full Text] [Related]
13. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
[TBL] [Abstract][Full Text] [Related]
14. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds.
Chan H; McKay C; Adams S; Wargon O
Pediatrics; 2013 Jun; 131(6):e1739-47. PubMed ID: 23650294
[TBL] [Abstract][Full Text] [Related]
15. Early and Late Histological and Ultrastructural Findings in Resected Infantile Capillary Hemangiomas Following Treatment with Topical Beta-Blocker Timolol Maleate 0.5.
Sipkova Z; Xue K; Mudhar HS; Wagner B; Hildebrand GD
Ocul Oncol Pathol; 2018 Sep; 4(2):100-106. PubMed ID: 30320089
[TBL] [Abstract][Full Text] [Related]
16. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
[TBL] [Abstract][Full Text] [Related]
17. Infantile hemangiomas, complications and treatments.
Cheng CE; Friedlander SF
Semin Cutan Med Surg; 2016 Sep; 35(3):108-16. PubMed ID: 27607318
[TBL] [Abstract][Full Text] [Related]
18. Topical Timolol for Infantile Haemangioma of the Orbit.
Hildebrand GD; Sipkova Z
Klin Monbl Augenheilkd; 2021 Oct; 238(10):1069-1076. PubMed ID: 34662921
[TBL] [Abstract][Full Text] [Related]
19. Complicated Infantile Hemangioma Successfully Treated with Topical Timolol 0.5% Solution: A Case Report.
Borkar N; Sharma A; Hota D
J Cutan Aesthet Surg; 2021; 14(4):440-442. PubMed ID: 35283589
[TBL] [Abstract][Full Text] [Related]
20. Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas.
Wu HW; Wang X; Zhang L; Zheng JW; Liu C; Wang YA
Front Oncol; 2018; 8():605. PubMed ID: 30619747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
